US16359R1032
US16359R1032
Chemed Corp
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.53B EUR | 6.14B EUR | 5.01B EUR | 5.87B EUR |
Enterprise Value | 6.74B EUR | 6.14B EUR | 5.23B EUR | 5.94B EUR |
Valuation Multiples | ||||
Trailing P/E | 25.14x | 29.6x | 19.3x | 22.12x |
Forward P/E | 18.16x | -- | -- | -- |
Price to Sales | 2.52x | 3.19x | 1.97x | 2.32x |
Price to Book | 7.83x | -- | 5.91x | 5.99x |
EV/Revenue | 2.6x | 3.19x | 2.06x | 2.35x |
EV/EBITDA | 16.17x | 18.71x | 12.59x | 13.93x |
Price to FCF (P/FCF) | 21.22x | 24.13x | 13.3x | 18.02x |
EV/FCF | 21.89x | 24.13x | 13.88x | 18.24x |
FCF Yield | 4.71% | 4.14% | 7.52% | 5.55% |